Announcements Trials
Browse Landscape

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Dermatologic 1

Conditions

Breast Neoplasms 19Lung Neoplasms 16Prostatic Neoplasms 12Colorectal Neoplasms 12Hematologic Neoplasms 7Hematopoietic and Lymphatic System Neoplasm 6Neoplasms 5Neoplasm Metastasis 5Lymphoma 5Ovarian Neoplasms 4Obesity-Related Malignant Neoplasm 4Melanoma 4Carcinoma, Non-Small-Cell Lung 4Triple Negative Breast Neoplasms 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pancreatic Neoplasms 3Multiple Myeloma 3Fatigue 3Anatomic Stage I Breast Cancer AJCC v8 3Advanced Malignant Solid Neoplasm 3Uterine Cervical Neoplasms 2Skin Carcinoma 2Papillomavirus Infections 2Malignant Solid Neoplasm 2Lymphoma, Follicular 2Leukemia, Myeloid, Acute 2Hematopoietic and Lymphoid System Neoplasm 2Healthy Subject 2Genital Neoplasms, Female 2Gastrointestinal Neoplasms 2

Interventions

Standard of Care 1Practice Guidelines as Topic 1Methods 1Interviews as Topic 1Educational Status 1Early Intervention, Educational 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Arthritis, Reactive × Educational Status × 1 year × Clear all
NCT04751396 2026-05-20

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

M.D. Anderson Cancer Center

Recruiting
125 enrolled
Dermatologic

Arthritis, Rheumatoid, Autoimmune Diseases, Colitis, Ulcerative, Crohn Disease, Lupus Erythematosus, Systemic, Melanoma, Psoriasis, Spondylitis, Ankylosing, Inflammatory Bowel Diseases, Arthritis, Psoriatic, Arthritis, Reactive

Data powered by HemOnc (CC BY 4.0) Colophon âš¡